HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biodurability/retention of Libby amphiboles in a case of mesothelioma.

Abstract
Mesothelioma is considered a signal tumor for exposure to asbestos (fibrous materials) and can occur decades after first exposure. The present case study reports on tissue burden of fibrous dust in a person who used a vermiculite material (Zonolite) as an attic insulator some 50 years prior to her death. The exposure occurred in two construction/renovation projects in her private residencies. She potentially had exposures to wall board/joint compounds during renovations. She additionally was reported to occasionally be involved in occupational activity, including drilling holes in presumed asbestos-containing electrical boxes. The tissue burden analysis revealed the presence of noncommercial amphibole asbestos fibers and consistent presence in the lung and lymph samples of Libby amphibole fibers. The findings of Libby amphibole fibers in human tissue can be attributed to exposure to Libby vermiculite. This study illustrates that analytical transmission electron microscopy can distinguish these structures from "asbestos" fibers. Further, the findings indicate that a population of these structures is biodurable and retained in the tissue years after first/last exposure.
AuthorsRonald F Dodson, Eugene J Mark, Lee W Poye
JournalUltrastructural pathology (Ultrastruct Pathol) Vol. 38 Issue 1 Pg. 45-51 (Feb 2014) ISSN: 1521-0758 [Electronic] England
PMID24134457 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Asbestos, Amphibole
Topics
  • Aged, 80 and over
  • Asbestos, Amphibole (adverse effects)
  • Female
  • Humans
  • Lung Neoplasms (chemically induced)
  • Mesothelioma (chemically induced)
  • Microscopy, Electron, Transmission

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: